CFDE Data Portal | Search PEBP4-AS1

	Label	Description
	PEBP4-AS1 Gene (Entity type)	ENSG00000248738 - PEBP4 antisense RNA 1
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE125862 2 V 1 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140441 temozolomide stem cell 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 8 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 5 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 5 DASATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE130246 enzalutamide UM 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

PEBP4-AS1

ENSG00000248738 - PEBP4 antisense RNA 1

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE125862 2 V 1 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up

A Gene Set from LINCS

GSE140441 temozolomide stem cell 2 v 0 human up

A Gene Set from LINCS

GSE135514 dasatinib 8 v 9 human up

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 5 v 10 human dn

A Gene Set from LINCS

GSE135514 8 V 5 DASATINIB HUMAN UP

A Gene Set from LINCS

GSE130246 enzalutamide UM 1 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.